114 filings
Page 5 of 6
8-K
blpog
11 May 21
Fusion Pharmaceuticals Announces First Quarter 2021 Financial Results
7:45am
DEF 14A
edicde bm
27 Apr 21
Definitive proxy
4:02pm
8-K
yo3o1rmaotcpq6 373y
2 Apr 21
Fusion Pharmaceuticals Announces Closing of Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
8:10am
8-K
ldjxf61n
2 Apr 21
Departure of Directors or Certain Officers
8:00am
SEC STAFF
wyi4kas
29 Mar 21
SEC staff action: Order
12:00am
S-8
uqpt 72m8
25 Mar 21
Registration of securities for employees
8:16am
10-K
nulrl90p61lidwjk
25 Mar 21
Annual report
8:01am
8-K
9jnycxv82gk85eeel 68
25 Mar 21
Fusion Pharmaceuticals Announces Fourth Quarter 2020 Financial Results
7:46am
8-K
7f3zj8h4fsu v4hd
2 Mar 21
Fusion Pharmaceuticals to Expand Pipeline with Acquisition of IPN-1087, a Small Molecule Targeting NTSR1, from Ipsen
9:00am
SEC STAFF
i1ua5utrwqc
1 Mar 21
SEC staff action: Order
12:00am
8-K
3n4pud7 ja
12 Feb 21
Fusion Pharmaceuticals Appoints Philina Lee, Ph.D., to
4:16pm
8-K
u467emlp58 sxvvh
10 Nov 20
Fusion Pharmaceuticals Announces Third Quarter 2020 Financial Results
7:15am
8-K
g0lrpvafiiqeh26
3 Nov 20
Fusion Pharmaceuticals Appoints Barbara Duncan as Chairperson of the Board of Directors
4:10pm
8-K
j22tsa
2 Nov 20
Entry into a Material Definitive Agreement
7:11am
10-Q
ecfh0k0 of00
11 Aug 20
Quarterly report
4:05pm
8-K
fxp6dvm
11 Aug 20
Fusion Pharmaceuticals Announces Second Quarter 2020 Financial Results
8:30am
S-8
xggd5
30 Jun 20
Registration of securities for employees
4:35pm
8-K
pfa ri6at
30 Jun 20
Amendments to Articles of Incorporation or Bylaws
4:01pm
424B4
kqv3 huo7gwemit
26 Jun 20
Prospectus supplement with pricing info
4:47pm